Weltruza Becomes the First Monthly Under-the-Skin Olanzapine Shot Approved for Adults with Schizophrenia, No Post-Injection Monitoring Needed

FDA approves Weltruza, a monthly under-the-skin olanzapine shot for schizophrenia with no post-injection monitoring. Trial results and side effects.

Have A Referral?